Hoth Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Rocket One

08/11/2024 21:40

* Hoth Therapeutics Inc  HOTH.OQ   HOTH.O  is expected
to show no
change in quarterly revenue when it reports  results on November
11 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Hoth Therapeutics Inc is
for a
loss of 34 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Hoth
Therapeutics
Inc is $4.00​, above​ its last closing price of $0.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.42       -0.43      -0.24     Beat    44.2
 Mar. 31 2024  -0.43       -0.43      -0.46     Missed  -7
 Dec. 31 2023  -0.49       -0.51      -0.32     Beat    37.3​
 Jan. 1 0001   -0.72       -0.72      -0.60     Beat    17.2
 ​​Jun.        -1.16       -1.16      -0.57     Beat    50.9
 30 2023                                                
 Mar. 31 2023  -0.87       -0.86      -0.88     Missed  -1.7​
 Dec. 31 2022  -2.67       -2.29      -2.86     Missed  -24.9
 Jan. 1 0001   -2.40       -2.39      -2.05     Beat    14.4
 This summary was machine generated November 8 at 21:38 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)